DUXAP8 has been reported to function as an oncogene in glioma [27], pancreatic cancer [14], bladder cancer [28, 29], gastric cancer [30], non-small-cell lung cancer [31] as well as renal cell carcinoma [32]. Here, DUXAP8 is linked to non-small cell lung carcinoma.